Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$231.26
neg -1.40
-0.59%
Today's Range: 230.94 - 233.47 | AGN Avg Daily Volume: 1,981,800
Last Update: 08/16/17 - 9:30 AM EDT
Volume: 1,964,554
YTD Performance: 10.06%
Open: $232.87
Previous Close: $232.64
52 Week Range: $184.50 - $256.80
Oustanding Shares: 334,306,189
Market Cap: 77,772,991,809
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 3 3 3 3
Hold 3 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.61 1.61 1.50 1.50
Latest Dividend: 0.70
Latest Dividend Yield: 1.20%
Dividend Ex-Date: 08/16/17
Price Earnings Ratio: -19.87
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
-19.87 8.00 36.20
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.28% -9.02% 7.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.30 0.70 0.19
Net Income 282.20 0.20 0.00
EPS 281.40 -8.20 0.00
Earnings for AGN:
EBITDA 5.58B
Revenue 14.57B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $4.17 $4.68 $16.22 $18.02
Number of Analysts 17 17 17 18
High Estimate $4.44 $4.89 $16.34 $18.66
Low Estimate $3.91 $4.27 $16.07 $17.18
Prior Year $3.32 $3.90 $13.51 $16.22
Growth Rate (Year over Year) 25.71% 20.02% 20.09% 11.10%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Paul Price

 | Aug 16, 2017 | 7:00 AM EDT
The drug stock deserved to go down, but the resulting selloff is an overreaction.
RMPIA
By

Doug Kass

 | Aug 15, 2017 | 2:46 PM EDT
After much volatility we see little volatility today.   The market bent a bit but didn't break in today's trading session.   …
RMPIA
By

Jim Cramer

 | Aug 9, 2017 | 4:18 PM EDT
This generation is making its presence felt all over.
RMPIA
By

Doug Kass

 | Aug 8, 2017 | 10:00 AM EDT
Jim "El Capitan' Cramer had a solid interview with the CEO of Allergan (AGN) last night on "Mad Money." A must watch! …
RMPIA
By

Doug Kass

 | Aug 7, 2017 | 5:01 PM EDT
The market stood its ground and then some today:   * A buy program was the last program standing. * The Nasdaq regained streng …
RMPIA
By

Bret Jensen

 | Aug 7, 2017 | 1:00 PM EDT
When one of these pays off, it can make up for a number of errant wagers.
RMPIA
By

Paul Price

 | Aug 7, 2017 | 7:00 AM EDT
'Buy low and sell high' is easier said than done, but you can fight your fear with TEVA.
RMPIA
By

Jim Cramer and the AAP Team

 | Aug 6, 2017 | 10:00 AM EDT
Callout: Results and guidance lift markets, dodging D.C. drama.
RMPIA
By

Doug Kass

 | Aug 4, 2017 | 2:27 PM EDT
Added to Allergan (AGN) at $242.83. 
RMPIA
By

Doug Kass

 | Aug 4, 2017 | 1:24 PM EDT
Further Teva (TEVA) losses are plaguing Allergan (AGN) today.
Hug declines in Advance Auto Parts (AAP) and Dick's Sporting Goods (DKS) made for great ch...
Pepsi is trading at new all time highs today. The stock is up 0.7% and is taking out major...
FIBOCALL: AAP down 22% "FIBOCALL: AAP opens much lower today. We took a look way back t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.